We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

American Sales Company, Inc. v. Novo Nordisk A/S et al

  1. November 18, 2014

    Novo Nordisk Pays $19M To Settle Prandin Antitrust Action

    Novo Nordisk A/S has agreed to pay $19 million to settle a putative class action in Michigan federal court accusing it of attempting to monopolize the market for popular diabetes treatment Prandin by pursuing sham infringement litigation against generic-drug makers.

  2. June 1, 2010

    Novo Nordisk Hit With Antitrust Action Over Prandin

    Novo Nordisk A/S has been slapped with a putative class action that accuses it of attempting to monopolize the market for popular diabetes treatment Prandin by pursuing sham infringement litigation against generic-drug makers.